Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ

Wyszukujesz frazę ""Alimentary pharmacology & therapeutics [Aliment Pharmacol Ther] NLMUID: 8707234"" wg kryterium: JN


Tytuł :
Progressive alcohol-related liver fibrosis is characterised by imbalanced collagen formation and degradation.
Autorzy :
Thiele M; Fibrosis, Fatty Liver and Steatohepatitis Research Centre Odense (FLASH), Department of Gastroenterology and Hepatology, Odense University Hospital, Odense, Denmark.; Department of Clinical Research, Faculty of Health Sciences, University of Southern Denmark, Odense, Denmark.
Johansen S; Fibrosis, Fatty Liver and Steatohepatitis Research Centre Odense (FLASH), Department of Gastroenterology and Hepatology, Odense University Hospital, Odense, Denmark.
Gudmann NS; Nordic Bioscience A/S, Herlev, Denmark.
Madsen B; Fibrosis, Fatty Liver and Steatohepatitis Research Centre Odense (FLASH), Department of Gastroenterology and Hepatology, Odense University Hospital, Odense, Denmark.
Kjaergaard M; Fibrosis, Fatty Liver and Steatohepatitis Research Centre Odense (FLASH), Department of Gastroenterology and Hepatology, Odense University Hospital, Odense, Denmark.
Nielsen MJ; Nordic Bioscience A/S, Herlev, Denmark.
Leeming DJ; Nordic Bioscience A/S, Herlev, Denmark.
Jacobsen S; Fibrosis, Fatty Liver and Steatohepatitis Research Centre Odense (FLASH), Department of Gastroenterology and Hepatology, Odense University Hospital, Odense, Denmark.
Bendtsen F; Gastro Unit, Medical Section, Hvidovre University Hospital, Hvidovre, Denmark.; Department of Clinical Medicine, Faculty of Health Sciences, University of Copenhagen, Hvidovre, Denmark.
Møller S; Department of Clinical Medicine, Faculty of Health Sciences, University of Copenhagen, Hvidovre, Denmark.; Department of Clinical Physiology and Nuclear Medicine, Centre for Functional and Diagnostic Imaging and Research, Hvidovre Hospital, Hvidovre, Denmark.
Detlefsen S; Department of Clinical Research, Faculty of Health Sciences, University of Southern Denmark, Odense, Denmark.; Department of Pathology, Odense University Hospital, Odense, Denmark.
Karsdal M; Nordic Bioscience A/S, Herlev, Denmark.; Department of Molecular Medicine, Faculty of Health Sciences, University of Southern Denmark, Odense, Denmark.
Krag A; Fibrosis, Fatty Liver and Steatohepatitis Research Centre Odense (FLASH), Department of Gastroenterology and Hepatology, Odense University Hospital, Odense, Denmark.; Department of Clinical Research, Faculty of Health Sciences, University of Southern Denmark, Odense, Denmark.
Pokaż więcej
Corporate Authors :
GALAXY Consortium
Źródło :
Alimentary pharmacology & therapeutics [Aliment Pharmacol Ther] 2021 Aug 24. Date of Electronic Publication: 2021 Aug 24.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Review article: non-alcoholic fatty liver disease and cardiovascular diseases: associations and treatment considerations.
Autorzy :
Polyzos SA; First Laboratory of Pharmacology, School of Medicine, Aristotle University of Thessaloniki, Thessaloniki, Greece.
Kechagias S; Department of Health, Medicine, and Caring Sciences, Linköping University, Linköping, Sweden.
Tsochatzis EA; UCL Institute for Liver and Digestive Health, Royal Free Hospital and UCL, London, UK.
Pokaż więcej
Źródło :
Alimentary pharmacology & therapeutics [Aliment Pharmacol Ther] 2021 Aug 20. Date of Electronic Publication: 2021 Aug 20.
Typ publikacji :
Journal Article; Review
Czasopismo naukowe
Tytuł :
Clinical features, therapeutic requirements and evolution of patients with Crohn's disease and upper gastrointestinal involvement (CROHNEX study).
Autorzy :
Sainz E; Barcelona, Spain.
Zabana Y; Barcelona, Spain.
Miguel I; Lleida, Spain.
Fernández-Clotet A; Barcelona, Spain.
Beltrán B; Valencia, Spain.
Núñez L; Madrid, Spain.
García MJ; Santander, Spain.
Martín-Arranz MD; Madrid, Spain.
Iglesias E; Córdoba, Spain.
Cañete F; Barcelona, Spain.
Gutiérrez A; Alicante, Spain.
Piqueras M; Barcelona, Spain.
Pérez-Martínez I; Oviedo, Spain.
Bujanda L; San Sebastián, Spain.
Rodríguez-Lago I; Bizkaia, Spain.
Casanova MJ; Madrid, Spain.
Navarro P; Valencia, Spain.
Vicente R; Zaragoza, Spain.
Merino O; Bilbao, Spain.
Algaba A; Madrid, Spain.
Rodríguez C; Navarra, Spain.
Huguet JM; Valencia, Spain.
Fernández-Bañares F; Barcelona, Spain.
Domènech E; Barcelona, Spain.
Esteve M; Barcelona, Spain.
Pokaż więcej
Corporate Authors :
ENEIDA registry of GETECCU
Źródło :
Alimentary pharmacology & therapeutics [Aliment Pharmacol Ther] 2021 Aug 18. Date of Electronic Publication: 2021 Aug 18.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Editorial: is tofacitinib another rescue option for acute severe ulcerative colitis?
Autorzy :
Honap S; IBD Centre, Guy's and St Thomas' NHS Foundation Trust, London, UK.; School of Immunology and Microbial Sciences, King's College, London, UK.
Pavlidis P; IBD Centre, Guy's and St Thomas' NHS Foundation Trust, London, UK.; School of Immunology and Microbial Sciences, King's College, London, UK.
Irving PM; IBD Centre, Guy's and St Thomas' NHS Foundation Trust, London, UK.; School of Immunology and Microbial Sciences, King's College, London, UK.
Pokaż więcej
Źródło :
Alimentary pharmacology & therapeutics [Aliment Pharmacol Ther] 2021 Aug; Vol. 54 (3), pp. 341-342.
Typ publikacji :
Editorial; Comment
MeSH Terms :
Colitis, Ulcerative*/drug therapy
Humans ; Piperidines/therapeutic use ; Pyrimidines/therapeutic use ; Pyrroles/therapeutic use
Opinia redakcyjna
Tytuł :
Editorial: inconclusive diagnosis of GERD: are new parameters in impedance-pHmetry ready for clinical use? Authors' reply.
Autorzy :
Ribolsi M; Malattie Apparato Digerente, Campus Bio Medico, Rome, Italy.
Frazzoni M; Fisiopatologia Digestiva, Nuovo Ospedale S.Agostino, Modena, Italy.
Marabotto E; Division of Gastroenterology, Department of Internal Medicine, University of Genoa, Genoa, Italy.
Cicala M; Malattie Apparato Digerente, Campus Bio Medico, Rome, Italy.
Savarino E; Gastroenterology, University of Padova, Padua, Italy.
Pokaż więcej
Źródło :
Alimentary pharmacology & therapeutics [Aliment Pharmacol Ther] 2021 Aug; Vol. 54 (4), pp. 498-499.
Typ publikacji :
Editorial; Comment
MeSH Terms :
Gastroesophageal Reflux*/diagnosis
Electric Impedance ; Humans ; Hydrogen-Ion Concentration
Opinia redakcyjna
Tytuł :
Letter: predictive factors for treatment discontinuation in IBD-anti-TNF trough levels and anti-drug antibodies.
Autorzy :
Demarzo MG; Gastroenterology Unit, Department of Internal Medicine, University of Genoa, IRCCS Ospedale Policlinico San Martino, Genoa, Italy.
Bodini G; Gastroenterology Unit, Department of Internal Medicine, University of Genoa, IRCCS Ospedale Policlinico San Martino, Genoa, Italy.
Giuliana E; Gastroenterology Unit, Department of Internal Medicine, University of Genoa, IRCCS Ospedale Policlinico San Martino, Genoa, Italy.
Zentilin P; Gastroenterology Unit, Department of Internal Medicine, University of Genoa, IRCCS Ospedale Policlinico San Martino, Genoa, Italy.
Giannini EG; Gastroenterology Unit, Department of Internal Medicine, University of Genoa, IRCCS Ospedale Policlinico San Martino, Genoa, Italy.
Pokaż więcej
Źródło :
Alimentary pharmacology & therapeutics [Aliment Pharmacol Ther] 2021 Aug; Vol. 54 (4), pp. 536-537.
Typ publikacji :
Letter; Comment
MeSH Terms :
Inflammatory Bowel Diseases*/drug therapy
Tumor Necrosis Factor Inhibitors*
Adalimumab/therapeutic use ; Antibodies ; Humans ; Infliximab
Opinia redakcyjna
Tytuł :
Comparative study of pregnancy outcomes in women with inflammatory bowel disease treated with thiopurines and/or anti-TNF: a French nationwide study 2010-2018.
Autorzy :
Meyer A; EPIPHARE, Épidémiologie des produits de santé, ANSM-CNAM, Denis, France.; Assistance Publique-Hôpitaux de Paris, Hôpital Bicêtre, Le Kremlin Bicêtre, France.; Université Paris-Saclay, Le Kremlin Bicêtre, France.
Drouin J; EPIPHARE, Épidémiologie des produits de santé, ANSM-CNAM, Denis, France.
Weill A; EPIPHARE, Épidémiologie des produits de santé, ANSM-CNAM, Denis, France.
Carbonnel F; Assistance Publique-Hôpitaux de Paris, Hôpital Bicêtre, Le Kremlin Bicêtre, France.; Université Paris-Saclay, Le Kremlin Bicêtre, France.
Dray-Spira R; EPIPHARE, Épidémiologie des produits de santé, ANSM-CNAM, Denis, France.
Pokaż więcej
Źródło :
Alimentary pharmacology & therapeutics [Aliment Pharmacol Ther] 2021 Aug; Vol. 54 (3), pp. 302-311. Date of Electronic Publication: 2021 Jun 23.
Typ publikacji :
Journal Article
MeSH Terms :
Colitis*
Inflammatory Bowel Diseases*/drug therapy
Inflammatory Bowel Diseases*/epidemiology
Premature Birth*/chemically induced
Premature Birth*/epidemiology
Female ; Humans ; Infant, Newborn ; Pregnancy ; Pregnancy Outcome/epidemiology ; Tumor Necrosis Factor Inhibitors
Czasopismo naukowe
Tytuł :
A survey of gastroenterologists in the United States on the use of central neuromodulators for treating irritable bowel syndrome.
Autorzy :
Nulsen B; Department of Medicine and Vatche and Tamar Manoukian Division of Digestive Diseases, David Geffen School of Medicine, University of California, Los Angeles, CA, USA.
LeBrett W; Department of Medicine and Vatche and Tamar Manoukian Division of Digestive Diseases, David Geffen School of Medicine, University of California, Los Angeles, CA, USA.
Drossman DA; Center for Education and Practice of Biopsychosocial Care, Drossman Gastroenterology, University of North Carolina, Chapel Hill, NC, USA.
Chang L; Department of Medicine and Vatche and Tamar Manoukian Division of Digestive Diseases, David Geffen School of Medicine, University of California, Los Angeles, CA, USA.
Pokaż więcej
Źródło :
Alimentary pharmacology & therapeutics [Aliment Pharmacol Ther] 2021 Aug; Vol. 54 (3), pp. 281-291. Date of Electronic Publication: 2021 Jun 20.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Gastroenterologists*
Gastroenterology*
Irritable Bowel Syndrome*/drug therapy
Humans ; Neurotransmitter Agents/therapeutic use ; Surveys and Questionnaires ; United States
Czasopismo naukowe
Tytuł :
Editorial: metformin for portal hypertension-old dog, new tricks?
Autorzy :
Palaniyappan N; NIHR Nottingham Biomedical Research Centre, Nottingham University Hospitals NHS Trust, University of Nottingham, Nottingham, UK.; School of Medicine, University of Nottingham, Nottingham, UK.
Fallowfield JA; Centre for Inflammation Research, Queen's Medical Research Institute, University of Edinburgh, Edinburgh, UK.
Pokaż więcej
Źródło :
Alimentary pharmacology & therapeutics [Aliment Pharmacol Ther] 2021 Aug; Vol. 54 (3), pp. 345-346.
Typ publikacji :
Editorial; Comment
MeSH Terms :
Hypertension, Portal*/drug therapy
Metformin*/therapeutic use
Humans
Opinia redakcyjna
Tytuł :
Editorial: metformin for portal hypertension-old dog, new tricks? Authors' reply.
Autorzy :
Rittig N; Steno Diabetes Center Aarhus, Aarhus University Hospital, Aarhus, Denmark.; Department and Laboratories of Diabetes and Hormone diseases, Aarhus University Hospital, Aarhus, Denmark.
Aagaard NK; Department of Hepatology & Gastroenterology, Aarhus University Hospital, Aarhus, Denmark.
Villadsen GE; Department of Hepatology & Gastroenterology, Aarhus University Hospital, Aarhus, Denmark.
Sandahl TD; Department of Hepatology & Gastroenterology, Aarhus University Hospital, Aarhus, Denmark.
Jessen N; Steno Diabetes Center Aarhus, Aarhus University Hospital, Aarhus, Denmark.; Department of Clinical Pharmacology, Aarhus University Hospital, Aarhus, Denmark.; Research Laboratories for Biochemical Pathology, Aarhus University Hospital, Aarhus, Denmark.
Grønbaek H; Department of Hepatology & Gastroenterology, Aarhus University Hospital, Aarhus, Denmark.
George J; Storr Liver Centre, Westmead Institute for Medical Research, Westmead Hospital and University of Sydney, Westmead, NSW, Australia.
Pokaż więcej
Źródło :
Alimentary pharmacology & therapeutics [Aliment Pharmacol Ther] 2021 Aug; Vol. 54 (3), pp. 347.
Typ publikacji :
Editorial; Research Support, Non-U.S. Gov't; Comment
MeSH Terms :
Hypertension, Portal*/drug therapy
Metformin*/therapeutic use
Humans ; Liver Cirrhosis
Raport
Tytuł :
Novel impedance-pH parameters are associated with proton pump inhibitor response in patients with inconclusive diagnosis of gastro-oesophageal reflux disease according to Lyon Consensus.
Autorzy :
Ribolsi M; Department of Digestive Diseases, Campus Bio Medico University of Rome, Roma, Italy.
Frazzoni M; Digestive Pathophysiology Unit, Baggiovara Hospital, Modena, Italy.
Marabotto E; Ospedale Policlinico San Martino, Genova, Italy.
De Carlo G; Department of Digestive Diseases, Campus Bio Medico University of Rome, Roma, Italy.
Ziola S; Ospedale Policlinico San Martino, Genova, Italy.
Maniero D; Gastroenterology Unit, Department of Surgery, Oncology and Gastroenterology, University of Padua, Padova, Italy.
Balestrieri P; Department of Digestive Diseases, Campus Bio Medico University of Rome, Roma, Italy.
Cicala M; Department of Digestive Diseases, Campus Bio Medico University of Rome, Roma, Italy.
Savarino E; Gastroenterology Unit, Department of Surgery, Oncology and Gastroenterology, University of Padua, Padova, Italy.
Pokaż więcej
Źródło :
Alimentary pharmacology & therapeutics [Aliment Pharmacol Ther] 2021 Aug; Vol. 54 (4), pp. 412-418. Date of Electronic Publication: 2021 Jun 28.
Typ publikacji :
Journal Article
MeSH Terms :
Gastroesophageal Reflux*/diagnosis
Gastroesophageal Reflux*/drug therapy
Proton Pump Inhibitors*/therapeutic use
Consensus ; Electric Impedance ; Esophageal pH Monitoring ; Humans ; Hydrogen-Ion Concentration
Czasopismo naukowe
Tytuł :
Systematic review: efficacy of escalated maintenance anti-tumour necrosis factor therapy in Crohn's disease.
Autorzy :
Mattoo VY; Faculty of Medicine, Dentistry and Health Sciences, Melbourne Medical School, The University of Melbourne, Melbourne, Vic., Australia.; Department of Gastroenterology, St Vincent's Hospital Melbourne, Melbourne, Vic., Australia.
Basnayake C; Faculty of Medicine, Dentistry and Health Sciences, Melbourne Medical School, The University of Melbourne, Melbourne, Vic., Australia.; Department of Gastroenterology, St Vincent's Hospital Melbourne, Melbourne, Vic., Australia.
Connell WR; Faculty of Medicine, Dentistry and Health Sciences, Melbourne Medical School, The University of Melbourne, Melbourne, Vic., Australia.; Department of Gastroenterology, St Vincent's Hospital Melbourne, Melbourne, Vic., Australia.
Ding N; Faculty of Medicine, Dentistry and Health Sciences, Melbourne Medical School, The University of Melbourne, Melbourne, Vic., Australia.; Department of Gastroenterology, St Vincent's Hospital Melbourne, Melbourne, Vic., Australia.
Kamm MA; Faculty of Medicine, Dentistry and Health Sciences, Melbourne Medical School, The University of Melbourne, Melbourne, Vic., Australia.; Department of Gastroenterology, St Vincent's Hospital Melbourne, Melbourne, Vic., Australia.
Lust M; Department of Gastroenterology, St Vincent's Hospital Melbourne, Melbourne, Vic., Australia.
Niewiadomski O; Department of Gastroenterology, St Vincent's Hospital Melbourne, Melbourne, Vic., Australia.
Thompson A; Faculty of Medicine, Dentistry and Health Sciences, Melbourne Medical School, The University of Melbourne, Melbourne, Vic., Australia.; Department of Gastroenterology, St Vincent's Hospital Melbourne, Melbourne, Vic., Australia.
Wright EK; Faculty of Medicine, Dentistry and Health Sciences, Melbourne Medical School, The University of Melbourne, Melbourne, Vic., Australia.; Department of Gastroenterology, St Vincent's Hospital Melbourne, Melbourne, Vic., Australia.
Pokaż więcej
Źródło :
Alimentary pharmacology & therapeutics [Aliment Pharmacol Ther] 2021 Aug; Vol. 54 (3), pp. 249-266. Date of Electronic Publication: 2021 Jun 21.
Typ publikacji :
Journal Article; Review; Systematic Review
MeSH Terms :
Crohn Disease*/drug therapy
Adalimumab/therapeutic use ; Adult ; Bayes Theorem ; Humans ; Infliximab/therapeutic use ; Remission Induction ; Treatment Outcome ; Tumor Necrosis Factor Inhibitors ; Tumor Necrosis Factor-alpha
Czasopismo naukowe
Tytuł :
The impact of body mass index on efficacy and safety in the tofacitinib OCTAVE ulcerative colitis clinical programme.
Autorzy :
Farraye FA; Inflammatory Bowel Disease Center, Department of Gastroenterology and Hepatology, Mayo Clinic, Jacksonville, FL, USA.
Qazi T; Digestive Disease and Surgery Institute, Cleveland Clinic, Cleveland, OH, USA.
Kotze PG; IBD Outpatient Clinics, Colorectal Surgery Unit, Cajuru University Hospital, Pontifical Catholic University of Paraná (PUCPR), Curitiba, Brazil.
Moore GT; Department of Gastroenterology, Monash Health, Melbourne, Vic., Australia.; School of Clinical Sciences at Monash Health, Monash University, Melbourne, Vic., Australia.
Mundayat R; Pfizer Inc, New York, NY, USA.
Lawendy N; Pfizer Inc, Collegeville, PA, USA.
Sharma PP; Pfizer Inc, New York, NY, USA.
Judd DT; Pfizer Inc, Collegeville, PA, USA.
Pokaż więcej
Źródło :
Alimentary pharmacology & therapeutics [Aliment Pharmacol Ther] 2021 Aug; Vol. 54 (4), pp. 429-440. Date of Electronic Publication: 2021 Jun 24.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Colitis, Ulcerative*/drug therapy
Body Mass Index ; Humans ; Piperidines ; Pyrimidines/adverse effects ; Pyrroles/adverse effects
Czasopismo naukowe
Tytuł :
Systematic review: societal cost of illness of inflammatory bowel disease is increasing due to biologics and varies between continents.
Autorzy :
van Linschoten RCA; Department of Gastroenterology & Hepatology, Franciscus Gasthuis & Vlietland, Rotterdam, the Netherlands.; Department of Gastroenterology & Hepatology, Erasmus Medical Center, Rotterdam, the Netherlands.
Visser E; Department of Gastroenterology & Hepatology, Franciscus Gasthuis & Vlietland, Rotterdam, the Netherlands.
Niehot CD; Medical Library, Erasmus Medical Center, Rotterdam, the Netherlands.
van der Woude CJ; Department of Gastroenterology & Hepatology, Erasmus Medical Center, Rotterdam, the Netherlands.
Hazelzet JA; Department of Public Health, Erasmus Medical Center, Rotterdam, the Netherlands.
van Noord D; Department of Gastroenterology & Hepatology, Franciscus Gasthuis & Vlietland, Rotterdam, the Netherlands.
West RL; Department of Gastroenterology & Hepatology, Franciscus Gasthuis & Vlietland, Rotterdam, the Netherlands.
Pokaż więcej
Źródło :
Alimentary pharmacology & therapeutics [Aliment Pharmacol Ther] 2021 Aug; Vol. 54 (3), pp. 234-248. Date of Electronic Publication: 2021 Jun 11.
Typ publikacji :
Journal Article; Review; Systematic Review
MeSH Terms :
Biological Products*/therapeutic use
Colitis, Ulcerative*/drug therapy
Crohn Disease*/drug therapy
Inflammatory Bowel Diseases*/drug therapy
Cost of Illness ; Health Care Costs ; Humans
Czasopismo naukowe
Tytuł :
Editorial: non-erosive reflux disease (NERD) is often not GERD-time to change the definition or abandon the term? Authors' reply.
Autorzy :
Kim SH; Division of Gastroenterology, Department of Internal Medicine, Guro Hospital, Korea University College of Medicine, Seoul, South Korea.
Park SH; Department of Gastroenterology, Catholic University Yeouido St. Mary's Hospital, Seoul, South Korea.
Pokaż więcej
Źródło :
Alimentary pharmacology & therapeutics [Aliment Pharmacol Ther] 2021 Aug; Vol. 54 (4), pp. 495.
Typ publikacji :
Editorial; Comment
MeSH Terms :
Gastroesophageal Reflux*/diagnosis
Gastroesophageal Reflux*/epidemiology
Humans
Opinia redakcyjna
Tytuł :
Editorial: natural history of hepatitis delta virus-induced liver disease - less severe today but still needs attention.
Autorzy :
Gençdal G; Department of Gastroenterology and Hepatology, Koç University Medical School, Istanbul, Turkey.
Zeybel M; Department of Gastroenterology and Hepatology, Koç University Medical School, Istanbul, Turkey.
Yurdaydin C; Department of Gastroenterology and Hepatology, Koç University Medical School, Istanbul, Turkey.
Pokaż więcej
Źródło :
Alimentary pharmacology & therapeutics [Aliment Pharmacol Ther] 2021 Aug; Vol. 54 (4), pp. 519-520.
Typ publikacji :
Editorial; Comment
MeSH Terms :
Hepatitis Delta Virus*
Liver Diseases*
Attention ; Hepatitis B Surface Antigens ; Humans ; Liver
Opinia redakcyjna
Tytuł :
Letter: response of eosinophilic oesophagitis to proton pump inhibitor therapy-the importance of biopsies at index endoscopy.
Autorzy :
Chen L; Department of Gastroenterology, Northern Hospital, Melbourne, Vic, Australia.
Glance S; Department of Gastroenterology, Northern Hospital, Melbourne, Vic, Australia.; Department of Medicine, University of Melbourne, Melbourne, Vic, Australia.
Garg M; Department of Gastroenterology, Northern Hospital, Melbourne, Vic, Australia.; Department of Medicine, University of Melbourne, Melbourne, Vic, Australia.
Pokaż więcej
Źródło :
Alimentary pharmacology & therapeutics [Aliment Pharmacol Ther] 2021 Aug; Vol. 54 (4), pp. 521-522.
Typ publikacji :
Letter; Comment
MeSH Terms :
Eosinophilic Esophagitis*/drug therapy
Proton Pump Inhibitors*/adverse effects
Biopsy ; Endoscopy ; Humans
Opinia redakcyjna
Tytuł :
One-quarter of chronic hepatitis D patients reach HDV-RNA decline or undetectability during the natural course of the disease.
Autorzy :
Palom A; Liver Unit, Hospital Universitari Vall d'Hebron, Barcelona, Spain.; Department of Medicine, Universitat Autònoma de Barcelona, Barcelona, Spain.
Sopena S; Biochemistry and Microbiology Department, Hospital Universitari Vall d'Hebron, Barcelona, Spain.
Riveiro-Barciela M; Liver Unit, Hospital Universitari Vall d'Hebron, Barcelona, Spain.; Department of Medicine, Universitat Autònoma de Barcelona, Barcelona, Spain.; Instituto de Salud Carlos III, Madrid, Spain.
Carvalho-Gomes A; Instituto de Salud Carlos III, Madrid, Spain.; Liver Transplantation and Hepatology Unit, Hospital U. y P. La Fe, Universitat de València, Valencia, Spain.
Madejón A; Instituto de Salud Carlos III, Madrid, Spain.; Liver Unit, Hospital Universitario La Paz, IdiPAZ, Madrid, Spain.
Rodriguez-Tajes S; Instituto de Salud Carlos III, Madrid, Spain.; Liver Unit, Hospital Clinic Barcelona, IDIBAPS, Universitat de Barcelona, Barcelona, Spain.
Roade L; Liver Unit, Hospital Universitari Vall d'Hebron, Barcelona, Spain.; Department of Medicine, Universitat Autònoma de Barcelona, Barcelona, Spain.; Instituto de Salud Carlos III, Madrid, Spain.
García-Eliz M; Liver Transplantation and Hepatology Unit, Hospital U. y P. La Fe, Universitat de València, Valencia, Spain.
García-Samaniego J; Instituto de Salud Carlos III, Madrid, Spain.; Liver Unit, Hospital Universitario La Paz, IdiPAZ, Madrid, Spain.
Lens S; Instituto de Salud Carlos III, Madrid, Spain.; Liver Unit, Hospital Clinic Barcelona, IDIBAPS, Universitat de Barcelona, Barcelona, Spain.
Berenguer-Hayme M; Instituto de Salud Carlos III, Madrid, Spain.; Liver Transplantation and Hepatology Unit, Hospital U. y P. La Fe, Universitat de València, Valencia, Spain.
Rodríguez-Frías F; Department of Medicine, Universitat Autònoma de Barcelona, Barcelona, Spain.; Biochemistry and Microbiology Department, Hospital Universitari Vall d'Hebron, Barcelona, Spain.; Instituto de Salud Carlos III, Madrid, Spain.
Hernandez-Évole H; Liver Transplantation and Hepatology Unit, Hospital U. y P. La Fe, Universitat de València, Valencia, Spain.
Isabel Gil-García A; Instituto de Salud Carlos III, Madrid, Spain.; Liver Unit, Hospital Universitario La Paz, IdiPAZ, Madrid, Spain.
Barreira A; Liver Unit, Hospital Universitari Vall d'Hebron, Barcelona, Spain.; Department of Medicine, Universitat Autònoma de Barcelona, Barcelona, Spain.; Instituto de Salud Carlos III, Madrid, Spain.
Esteban R; Liver Unit, Hospital Universitari Vall d'Hebron, Barcelona, Spain.; Department of Medicine, Universitat Autònoma de Barcelona, Barcelona, Spain.; Instituto de Salud Carlos III, Madrid, Spain.
Buti M; Liver Unit, Hospital Universitari Vall d'Hebron, Barcelona, Spain.; Department of Medicine, Universitat Autònoma de Barcelona, Barcelona, Spain.; Instituto de Salud Carlos III, Madrid, Spain.
Pokaż więcej
Źródło :
Alimentary pharmacology & therapeutics [Aliment Pharmacol Ther] 2021 Aug; Vol. 54 (4), pp. 462-469. Date of Electronic Publication: 2021 Jun 28.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Hepatitis D*/diagnosis
Hepatitis D*/epidemiology
Hepatitis D, Chronic*/drug therapy
DNA, Viral ; Hepatitis B Surface Antigens ; Hepatitis B virus/genetics ; Hepatitis Delta Virus/genetics ; Humans ; Male ; Middle Aged ; RNA
Czasopismo naukowe
Tytuł :
Editorial: trends in alcohol use and alcohol-related liver disease in the US population.
Autorzy :
Barnard A; Division of Gastroenterology, Department of Medicine, University of California at San Diego, San Diego, CA, USA.
Dave S; Division of Gastroenterology, Department of Medicine, University of California at San Diego, San Diego, CA, USA.
Pokaż więcej
Źródło :
Alimentary pharmacology & therapeutics [Aliment Pharmacol Ther] 2021 Aug; Vol. 54 (4), pp. 511-512.
Typ publikacji :
Editorial; Comment
MeSH Terms :
Alcohol Drinking*/adverse effects
Alcohol Drinking*/epidemiology
Liver Diseases*/epidemiology
Liver Diseases*/etiology
Humans
Opinia redakcyjna
Tytuł :
Editorial: assessment of inflammatory bowel disease: a picture is worth a thousand words. Authors' reply.
Autorzy :
Friedman AB; Department of Gastroenterology, Alfred Health and Monash University, Melbourne, Vic, Australia.
Gibson PR; Department of Gastroenterology, Alfred Health and Monash University, Melbourne, Vic, Australia.
Pokaż więcej
Źródło :
Alimentary pharmacology & therapeutics [Aliment Pharmacol Ther] 2021 Aug; Vol. 54 (4), pp. 510.
Typ publikacji :
Editorial; Comment
MeSH Terms :
Colitis*
Inflammatory Bowel Diseases*/diagnosis
Humans
Opinia redakcyjna

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies